Literature DB >> 21333899

Traditional thoughts on the pathophysiology of irritable bowel syndrome.

William L Hasler1.   

Abstract

The pathogenesis of symptoms in irritable bowel syndrome (IBS) is multifactorial and varies from patient to patient. Disturbances of motor function in the small intestine and colon and smooth-muscle dysfunction in other gut and extraintestinal regions are prominent. Abnormalities of sensory function in visceral and somatic structures are detected in most patients with IBS, which may relate to peripheral sensitization or altered central nervous system processing of afferent information. Contributions from psychosocial disturbances are observed in patients from tertiary centers and primary practice. Proof of causation of symptom genesis for most of these factors is limited.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21333899     DOI: 10.1016/j.gtc.2010.12.004

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  14 in total

Review 1.  High amplitude propagated contractions.

Authors:  A E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2012-11       Impact factor: 3.598

2.  Novel Therapies in IBS-D Treatment.

Authors:  Judy Nee; Mohammed Zakari; Anthony J Lembo
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12

Review 3.  The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D).

Authors:  Yang Won Min; Poong-Lyul Rhee
Journal:  Therap Adv Gastroenterol       Date:  2015-05       Impact factor: 4.409

4.  Efficacy of ramosetron in male patients with irritable bowel syndrome with diarrhea (neurogastroenterol motil 2011;23:1098-1104).

Authors:  Bong Ki Cha; Chang Hwan Choi; Sae Kyung Chang
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

Review 5.  Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.

Authors:  Susan Lucak; Lin Chang; Albena Halpert; Lucinda A Harris
Journal:  Therap Adv Gastroenterol       Date:  2016-09-16       Impact factor: 4.409

Review 6.  Recent advances in pharmacological treatment of irritable bowel syndrome.

Authors:  Georgia Lazaraki; Grigoris Chatzimavroudis; Panagiotis Katsinelos
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

7.  Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.

Authors:  William D Chey; Monthira Maneerattaporn; Richard Saad
Journal:  Gut Liver       Date:  2011-08-18       Impact factor: 4.519

8.  Dose Irritable Bowel Syndrome and Dysmotility Have an Autoimmune Origin? (Neurogastroenterol Motil 2011;23:1000-1006, e459).

Authors:  Jeong Eun Shin
Journal:  J Neurogastroenterol Motil       Date:  2012-01-16       Impact factor: 4.924

9.  Irritable bowel syndrome - An inflammatory disease involving mast cells.

Authors:  Hamish Philpott; Peter Gibson; Frank Thien
Journal:  Asia Pac Allergy       Date:  2011-04-26

10.  Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome.

Authors:  Rocchina Colucci; Dario Gambaccini; Narcisa Ghisu; Giuseppe Rossi; Francesco Costa; Marco Tuccori; Nicola De Bortoli; Matteo Fornai; Luca Antonioli; Angelo Ricchiuti; Maria Gloria Mumolo; Santino Marchi; Corrado Blandizzi; Massimo Bellini
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.